作者:
Joel T,Rämö [1]
;
Erik,Abner [2]
;
Elon H C,van Dijk [3]
;
Xin,Wang [4]
;
Joost,Brinks [2]
;
Tiit,Nikopensius [3]
;
Margit,Nõukas [5]
;
Heidi,Marjonen [6]
;
Kaisa,Silander [6]
;
Sakari,Jukarainen [7]
;
Tuomo,Kiiskinen [7]
;
Seung Hoan,Choi [8]
;
Risto,Kajanne [7]
;
Juha,Mehtonen [7]
;
Priit,Palta [9]
;
Steven A,Lubitz [10]
;
Kai,Kaarniranta [11]
;
Lucia,Sobrin [12]
;
Mitja,Kurki [13]
;
Suzanne,Yzer [14]
;
Patrick T,Ellinor [10]
;
Tõnu,Esko [15]
;
Mark J,Daly [16]
;
Anneke I,den Hollander [17]
;
Aarno,Palotie [18]
;
Joni A,Turunen [19]
;
Camiel J F,Boon [20]
;
Elizabeth J,Rossin [21]
;
FinnGen Study ;
Estonian Biobank Research Team
作者单位:
Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.;Massachusetts Eye and Ear, Boston.;Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.;Cardiovascular Research Center, Massachusetts General Hospital, Boston.
[1]
Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands.
[2]
Estonian Genome Center, University of Tartu, Tartu, Estonia.
[3]
Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
[4]
Estonian Genome Center, University of Tartu, Tartu, Estonia.;Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia.
[5]
Finnish Institute for Health and Welfare, Helsinki, Finland.
[6]
Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
[7]
Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.;Department of Biostatistics, Boston University, Boston, Massachusetts.
[8]
Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.;Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands.
[9]
Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.;Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston.
[10]
Department of Ophthalmology, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.
[11]
Harvard Medical School Department of Ophthalmology, Massachusetts Eye and Ear, Boston.
[12]
Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.;Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.;Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts General Hospital and Harvard Medical School, Boston.
[13]
Department of Ophthalmology, Radboud University Medical Center, Nijmegen, the Netherlands.;Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands.
[14]
Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands.;Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia.
[15]
Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.;Analytic and Translational Genetics Unit, Massachusetts General Hospital and Harvard Medical School, Boston.;Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
[16]
Department of Ophthalmology, Radboud University Medical Center, Nijmegen, the Netherlands.;Genomics Research Center, AbbVie, Cambridge, Massachusetts.
[17]
Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.;Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts General Hospital and Harvard Medical School, Boston.;Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.;Department of Neurology, Massachusetts General Hospital, Boston.;Analytic and Translational Genetics Unit, Massachusetts General Hospital and Harvard Medical School, Boston.
[18]
Folkhälsan Research Center, Biomedicum, Helsinki, Finland.;Department of Ophthalmology, University of Helsinki, Helsinki, Finland.
[19]
Estonian Genome Center, University of Tartu, Tartu, Estonia.;Department of Ophthalmology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
[20]
Harvard Medical School Department of Ophthalmology, Massachusetts Eye and Ear, Boston.;Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
[21]
主题词
人类(Humans);女(雌)性(Female);中心性浆液性脉络膜视网膜病变(Central Serous Chorioretinopathy);全基因组关联研究(Genome-Wide Association Study);内皮细胞(Endothelial Cells);基因座(Genetic Loci);黄斑变性(Macular Degeneration)
DOI
10.1001/jamaophthalmol.2023.0706
PMID
37079300
发布时间
2024-09-18
- 浏览2

JAMA ophthalmology
JAMA ophthalmology
2023年141卷5期
449-457页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文